BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kinoshita Y, Kazumori H, Ishihara S. Treatment of proton pump inhibitor-resistant patients with gastroesophageal reflux disease. J Gastroenterol 2006;41:286-7. [PMID: 16699865 DOI: 10.1007/s00535-006-1756-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Kinoshita Y, Hongo M, Kusano M, Furuhata Y, Miyagishi H, Ikeuchi S; RPZ Study Group. Therapeutic Response to Twice-daily Rabeprazole on Health-related Quality of Life and Symptoms in Patients with Refractory Reflux Esophagitis: A Multicenter Observational Study. Intern Med. 2017;56:1131-1139. [PMID: 28502925 DOI: 10.2169/internalmedicine.56.7896] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
2 Kinoshita Y, Hongo M; Japan TWICE Study Group. Efficacy of twice-daily rabeprazole for reflux esophagitis patients refractory to standard once-daily administration of PPI: the Japan-based TWICE study. Am J Gastroenterol 2012;107:522-30. [PMID: 22433921 DOI: 10.1038/ajg.2012.19] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.9] [Reference Citation Analysis]